Proteinases in bone resorption:: obvious and less obvious roles

被引:158
作者
Delaissé, JM
Engsig, MT
Everts, V
Ovejero, MD
Ferreras, M
Lund, L
Vu, TH
Werb, Z
Winding, B
Lochter, A
Karsdal, MA
Troen, T
Kirkegaard, T
Lenhard, T
Heegaard, AM
Neff, L
Baron, R
Foged, NT
机构
[1] Ctr Clin & Basic Res, DK-2750 Ballerup, Denmark
[2] AMC, Amsterdam, Netherlands
[3] ACTA, Amsterdam, Netherlands
[4] Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark
[5] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
[6] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA
关键词
bone resorption; cathepsin K; matrix metalloproteinase (MMP); collagenase; MMP-9; osteoclast; osteoblast;
D O I
10.1016/S0009-8981(99)00230-2
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Bone resorption is critical for the development and the maintenance of the skeleton, and improper regulation of bone resorption leads to pathological situations. Proteinases are necessary for this process. Ln this review, we show that this need of proteinases is not only because they are required for the solubilization of bone matrix, but also because they are key components of the mechanism that determines where and when bone resorption will be initiated. Moreover, there are indications that proteinases may also determine whether resorption will be followed by bone formation. Some of the proteinases involved in these different steps of the resorption processes were recently identified, as for instance cathepsin K, MMP-9 (gelatinase B), and interstitial collagenase. However, there is also increasing evidence showing that the critical proteinase(s) may vary depending on the bone type or on other factors. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:223 / 234
页数:12
相关论文
共 101 条
  • [81] Alendronate blocks metalloproteinase secretion and bone collagen I release by PC-3 ML cells in SCID mice
    Stearns, ME
    Wang, M
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 1998, 16 (08) : 693 - 702
  • [82] Suda Tatsuo, 1996, P87
  • [83] Takagi M, 1998, LAB INVEST, V78, P735
  • [84] Takei I, 1999, J BIOMED MATER RES, V45, P175, DOI 10.1002/(SICI)1097-4636(19990605)45:3<175::AID-JBM3>3.0.CO
  • [85] 2-9
  • [86] Factors related to degradation of articular cartilage in osteoarthritis: A review
    Tanaka, S
    Hamanishi, C
    Kikuchi, H
    Fukuda, K
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1998, 27 (06) : 392 - 399
  • [87] TEZUKA K, 1994, J BIOL CHEM, V269, P1106
  • [88] TEZUKA K, 1994, J BIOL CHEM, V269, P15006
  • [89] Design of potent and selective human cathepsin K inhibitors that span the active site
    Thompson, SK
    Halbert, SM
    Bossard, MJ
    Tomaszek, TA
    Levy, MA
    Zhao, BG
    Smith, WW
    Abdel-Meguid, SS
    Janson, CA
    D'Alessio, KJ
    McQueney, MS
    Amegadzie, BY
    Hanning, CR
    DesJarlais, RL
    Briand, J
    Sarkar, SK
    Huddleston, MJ
    Ijames, CF
    Carr, SA
    Garnes, KT
    Shu, A
    Heys, JR
    Bradbeer, J
    Zembryki, D
    Lee-Rykaczewski, L
    James, IE
    Lark, MW
    Drake, FH
    Gowen, M
    Gleason, JG
    Veber, DF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) : 14249 - 14254
  • [90] Ueda Y, 1996, AM J PATHOL, V148, P611